Curative Biosciences logo

Curative Biosciences(OTC) CBDX

Market Cap$25.80KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2010)-100%
5 Year-100%
1 Year+0%
1 Month+0%
$0.00
+0.00%
+0.00Today
Curative Biosciences last closing stock price
MetricPriceDate
Last closeUSD 0.002026-07-29
Curative Biosciences stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 0.002026-07-15
1 month+0%USD 0.002026-06-10
3 month+0%USD 0.002026-04-30
Year to date+0%USD 0.002025-12-31
1 year+0%USD 0.002025-07-15
3 year-92.86%USD 0.002023-07-13
5 year-99.91%USD 0.112021-07-30
Since inception-100%USD 5,050.002010-11-29

Curative Biosciences Financials at a Glance

Market Cap

$25.80KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

N/A

Net Income (TTM)

N/A

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-19.52 (Low)

Price

$0.00

Volume

200

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

May 15, 2018

CBDX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Curative Biosciences

Curative Biosciences, Inc. is focused on developing and commercializing therapeutics using hemp-derived Cannabidiol. The company aims to manufacture and market natural health products within the medical cannabis industry.

Products and Services
  • Therapeutics utilizing hemp-derived Cannabidiol
  • Natural health products targeting various health conditions
  • Innovative solutions in the medical cannabis sector
Growth Outlook
  • Market demand for hemp-derived products is increasing rapidly
  • Expansion opportunities in the medical cannabis industry are significant
  • Potential for product diversification to capture broader consumer base
Financial Highlights
  • Market capitalization stands at approximately $25,789
  • Stock price has fluctuated between $0.0001 and $0.0002 in the past year
  • Trailing twelve months show a negative price-to-earnings ratio of -0.029
Curative Biosciences, Inc. operates in a rapidly evolving industry with increasing consumer interest in natural health solutions. The company's focus on hemp-derived Cannabidiol positions it well to capitalize on the growing market for medical cannabis products. Despite current financial challenges, the potential for growth remains strong, driven by expanding market opportunities and consumer demand. Investors may find the company's innovative approach and strategic positioning within the industry noteworthy as it navigates the complexities of the healthcare sector.
AI Generated • Oct 6, 2026

Industry

Pharmaceuticals

Sector

Health Care

Headquarters

Miami, FL 33131, US

CBDX Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

8.54%

Return on Capital

N/A

Return on Assets

-2348.57%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$25.80KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

257.89M

Volume

200

Avg. Volume

18.462

Financials (TTM)

Gross Profit

-$2.85K

Operating Income

-$53.20K

EBITDA

-$50.35K

Operating Cash Flow

-$12.80K

Capital Expenditure

$0.00

Free Cash Flow

-$12.80K

Cash & ST Invst.

$0.00

Total Debt

$62.83K

Curative Biosciences Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
CurrentYOY CHG

Revenue

N/A

N/A

Gross Profit

N/A

N/A

Gross Margin

N/A

N/A

Market Cap

$25.80KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

N/A

N/A

EBITDA

N/A

N/A

Quarterly Fundamentals

Name
CurrentYOY CHG

Total Cash

N/A

N/A

Total Debt

N/A

N/A

Accounts Receivable

N/A

N/A

Inventory

N/A

N/A

Long Term Debt

N/A

N/A

Short Term Debt

N/A

N/A

Return on Assets

N/A

N/A

Return on Invested Capital

N/A

N/A

Free Cash Flow

N/A

N/A

Operating Cash Flow

N/A

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
GMVDFG Medical Innovations Holdings Ltd
$0.00+0.00%
MCRTMicroart Inc.
$0.00+0.00%
AZFLAmazonas Florestal, Ltd
$0.00+0.00%
CNNCCannonau Corp.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF
$33.76+10.14%
BITOProShares Trust - ProShares Bitcoin ETF
$10.89-2.25%
INTCIntel
$106.52-5.83%
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$142.57-10.28%

Questions About CBDX

What is the current price of Curative Biosciences?

Curative Biosciences is trading at $0.00 per share.

What is the 52-week range for Curative Biosciences?

Over the past 52 weeks, Curative Biosciences has traded between $0.00 and $0.00.

How much debt does Curative Biosciences have?

Curative Biosciences total debt is unavailable.

How much cash does Curative Biosciences have on hand?

Curative Biosciences does not have cash on hand data available.

What is Curative Biosciences’s dividend yield?

Curative Biosciences does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services